Latest Funding Risk News

Tinybeans Group has completed a partially underwritten entitlement offer, raising $1.7 million to support growth and working capital, with plans to place the remaining shortfall soon.

Rent.com.au has locked in up to $5.5 million in growth capital by underwriting the exercise of its remaining listed options, positioning the company for accelerated profitability and expansion of its RentBond® loan book.

Algorae Pharmaceuticals has secured a $384,466 cash refund from the Australian Taxation Office, reinforcing its financial position to advance AI-driven drug discovery programs.

Adelong Gold Limited has agreed to sell its remaining 49% stake in Challenger Mines to Great Divide Mining for 10 million shares valued at approximately AUD 3.1 million, while retaining a 1% royalty on future gold production.

Cluey Ltd has formalised its acquisition of Education Futures Group, the parent of Art of Smart, in a deal valued up to $6.5 million combining cash and shares. Completion is expected by January 2026, contingent on conditions and an ongoing entitlement offer.

Antares Metals Limited has voluntarily suspended trading of its shares pending a significant announcement about a proposed acquisition and capital raising, expected by 8 December 2025.

Kula Gold Limited’s board unanimously recommends shareholders accept Forrestania Resources’ off-market takeover offer, valuing Kula shares at a significant premium and promising reduced funding risks and exposure to a stronger combined gold portfolio.

Ore Resources Ltd has secured an option to acquire a new tenement adjacent to its Randalls Gold Project, significantly expanding its landholdings and identifying promising drill targets with strong historical gold intercepts.

Ryzon Materials Ltd has lodged a prospectus to raise up to $10 million through a share placement with free-attaching options, aiming to meet ASX conditions for lifting its securities suspension and advancing its Nachu graphite project.

Chimeric Therapeutics has received a $4.5 million R&D tax incentive refund from the Australian Government, underscoring its ongoing investment in innovative cancer cell therapies.

ReadCloud Limited reported a robust FY25 with a 109% surge in underlying EBITDA, driven by strong growth in its Australian school businesses. The company’s FY26 outlook targets continued organic expansion and disciplined execution amid industry funding uncertainties.

ReadCloud Limited reported a 5% revenue increase to $12.9 million for FY25, alongside a 109% surge in underlying EBITDA to $0.76 million, narrowing its statutory loss by 59%. Strong growth in its VET-in-Schools segment and domestic eBooks sales underpinned this improved financial performance.